Journal of Clinical Lipidology
Scope & Guideline
Advancing lipid science for healthier hearts.
Introduction
Aims and Scopes
- Lipid Disorders and Genetic Factors:
The journal emphasizes research on genetic predispositions to lipid disorders, particularly familial hypercholesterolemia, dyslipidemia, and related metabolic syndromes. This includes studies on genetic mutations, their phenotypic expressions, and implications for diagnostics and treatment. - Clinical Management of Lipid Disorders:
A significant focus is placed on the clinical management of patients with lipid disorders, including the effectiveness of various pharmacotherapies, dietary interventions, and lifestyle modifications aimed at reducing cardiovascular risk. - Innovative Therapeutic Approaches:
The journal highlights novel therapeutic strategies, such as PCSK9 inhibitors, antisense oligonucleotides, and other lipid-lowering agents, along with their clinical outcomes and safety profiles. - Epidemiology and Public Health:
Research addressing the epidemiology of lipid disorders, their prevalence in different populations, and the impact of public health initiatives on lipid management and cardiovascular disease prevention is a key area of interest. - Implementation Science in Lipidology:
The journal explores the application of implementation science to improve lipid screening, diagnosis, and management protocols within clinical settings, enhancing patient outcomes and healthcare delivery.
Trending and Emerging
- Familial Hypercholesterolemia and Genetic Testing:
Research on familial hypercholesterolemia, including genetic testing and screening guidelines, has surged. This reflects a growing recognition of the importance of early diagnosis and management of genetically predisposed individuals to prevent cardiovascular events. - Lipoprotein(a) and Cardiovascular Risk:
There is an increasing focus on lipoprotein(a) as an independent risk factor for cardiovascular disease, with studies investigating its measurement, clinical implications, and management strategies, indicating a significant shift in understanding lipid-related risks. - Implementation of Novel Therapies:
The journal is trending towards studies evaluating the real-world effectiveness and safety of novel lipid-lowering therapies, particularly PCSK9 inhibitors and RNA-based treatments, as they become more integrated into clinical practice. - Diversity and Disparities in Lipid Management:
Emerging themes include the examination of disparities in access to lipid management therapies across different populations, including racial, ethnic, and socioeconomic factors that influence treatment outcomes. - Lipidomics and Precision Medicine:
Research integrating lipidomics into clinical practice is gaining traction, focusing on personalized approaches to lipid management based on individual lipid profiles and genetic backgrounds, reflecting a move towards precision medicine in lipidology.
Declining or Waning
- Traditional Dietary Approaches:
There is a noticeable decline in studies focusing on traditional dietary approaches to managing dyslipidemia, such as low-fat diets, as newer research emphasizes the role of specific dietary components like omega-3 fatty acids and the Mediterranean diet. - Basic Lipid Biochemistry Studies:
Research centered solely on basic lipid biochemistry without clinical implications is becoming less prevalent. The journal is now favoring studies that translate biochemical findings into clinical practice or patient outcomes. - Historical Case Studies:
The frequency of historical case studies documenting rare lipid disorders is decreasing, possibly due to a shift towards more contemporary clinical trials and cohort studies that provide more relevant data for current practices. - Single-Center Studies:
There is a waning interest in single-center studies that do not incorporate broader epidemiological data. The journal is increasingly prioritizing multi-center or population-based studies that provide more comprehensive insights. - Non-Pharmacological Interventions:
Research focusing on non-pharmacological interventions alone, such as exercise or lifestyle changes without pharmacotherapy, appears to be less frequent, as there is a stronger emphasis on integrated approaches combining medication and lifestyle modifications.
Similar Journals
DIABETES OBESITY & METABOLISM
Delivering cutting-edge research for a healthier future.DIABETES OBESITY & METABOLISM, published by Wiley, is a premier international journal dedicated to the fields of endocrinology, diabetes, and metabolic disorders. With an impressive impact factor and its status as a Q1 journal in multiple categories—including Endocrinology and Internal Medicine—this publication is highly regarded in the academic community. Since its inception in 1999, the journal has served as a crucial platform for the dissemination of cutting-edge research, reviews, and clinical studies, driving advancements in understanding and treatment of diabetes and obesity. Researchers and professionals alike benefit from its rigorous peer-review process and extensive reach, as it aims to bridge the gap between laboratory findings and clinical applications. Although not an Open Access journal, articles are accessible through institutional subscriptions, ensuring that vital knowledge reaches those committed to enhancing patient care and expanding the scientific body of work in these pivotal areas.
Journal of Atherosclerosis and Thrombosis
Shaping the future of cardiovascular care with cutting-edge insights.Journal of Atherosclerosis and Thrombosis is a leading academic publication dedicated to advancing research in the fields of cardiovascular medicine, biochemistry, and internal medicine. Published by the Japan Atherosclerosis Society, this esteemed journal operates from its headquarters in Tokyo, Japan, and has been a vital resource in its area since its inception in 1994. With its robust impact in Cardiology and Cardiovascular Medicine, ranking in the top quartile (Q1) as of 2023, and a commendable standing in Internal Medicine and Biochemistry, the journal fosters an environment of innovation and discovery, showcasing significant studies and advancements that shape clinical practices and therapeutic approaches. Though not an open-access publication, it offers a wealth of insights to researchers, professionals, and students seeking to deepen their understanding of atherosclerosis and thrombosis. By continually featuring high-quality articles, the Journal of Atherosclerosis and Thrombosis plays an essential role in bridging the gap between research and practice, facilitating critical conversations that influence the future of cardiovascular health.
LIPIDS is a renowned peer-reviewed journal published by Wiley, dedicated to the field of lipid research, encompassing biochemistry, molecular biology, and organic chemistry. With its roots dating back to 1966 and a commitment to advancing knowledge until 2024, this journal serves as a vital platform for sharing significant findings in lipid biochemistry and its applications in health and disease. Although it currently does not offer Open Access options, it maintains a respectable standing with a Q3 ranking in Biochemistry and Organic Chemistry, and a Q4 ranking in Cell Biology based on the 2023 category quartiles. Additionally, its Scopus rankings reflect a solid position within the organic chemistry and biochemistry subfields. Published from Germany, LIPIDS caters to researchers, professionals, and students eager to explore the roles of lipids in biological processes and innovatory applications in various scientific disciplines.
Cancer & Metabolism
Fostering Collaboration in Cancer and Metabolic ResearchCancer & Metabolism is a distinguished open-access journal published by BMC, dedicated to advancing the understanding of the complex interactions between cancer biology and metabolic processes. Since its inception in 2013, it has provided a platform for researchers, clinicians, and students to disseminate groundbreaking research and innovative findings within the fields of oncology and metabolism. The journal, identified by its E-ISSN 2049-3002, is recognized for contributing valuable insights into metabolic alterations that influence cancer progression, treatment responses, and overall patient outcomes. With a firm commitment to open access, Cancer & Metabolism ensures that research is freely available to the global scientific community, fostering collaboration and accelerating discoveries that can lead to improved therapeutic strategies. As a vital resource in cancer research, this journal appeals to a broad audience, including researchers looking to share their latest findings, professionals seeking to stay informed on cutting-edge developments, and students eager to delve into the relationship between metabolism and cancer.
EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY
Connecting researchers to the forefront of lipid knowledge.EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY, published by WILEY, is a reputable academic journal dedicated to advancing the field of lipid science and technology. With an ISSN of 1438-7697 and E-ISSN 1438-9312, this journal serves as a critical resource for researchers, professionals, and students interested in the bioengineering, industrial applications, and nutritional science of lipids. Covering a broad spectrum from biochemistry to food science, it holds distinguished rankings across multiple categories, including Q2 in Chemistry and Food Science, and Q3 in Biotechnology, showcasing its significance in the interdisciplinary study of lipids. The journal welcomes Open Access options, fostering the dissemination of knowledge and innovation in lipid research. With converged years extending from 2000 to 2024, this journal remains at the forefront of lipid-related research, encouraging scholarly contributions that push the boundaries of science and technology.
Journal of Nutrition and Metabolism
Transforming Research into Nutritional ExcellenceJournal of Nutrition and Metabolism, published by HINDAWI LTD, is a prominent peer-reviewed, open-access journal that has been serving the scientific community since 2010. Based in Egypt, this journal is dedicated to advancing the field of nutrition and metabolism, providing a platform for innovative research that spans endocrinology, diabetes, food science, and dietetics. With a consistent commitment to accessibility, it embraces open-access policies to facilitate wider dissemination of knowledge, ensuring that researchers, professionals, and students can freely engage with pivotal studies and findings. The journal is currently indexed with an impressive standing in various categories, including being positioned in Q2 in Food Science and Q3 in Endocrinology, Diabetes and Metabolism. Furthermore, it ranks among the top journals in its fields on Scopus, reflecting its significance and impact within the research community. With a focus on robust, evidence-based studies that inform dietary practices and metabolic health, the Journal of Nutrition and Metabolism plays a crucial role in addressing the challenges of modern nutrition.
CHEMISTRY AND PHYSICS OF LIPIDS
Exploring the intricate world of lipid chemistry and biophysics.Chemistry and Physics of Lipids is a prestigious and influential journal dedicated to advancing the understanding of lipid chemistry and biophysics. Published by Elsevier Ireland Ltd, it serves as a vital resource for researchers and professionals in the fields of biochemistry, cell biology, and molecular biology. The journal has a strong standing within the academic community, as reflected in its 2023 Scopus rankings, where it places in the 82nd percentile for organic chemistry and maintains significant positions in various biochemistry subfields. Spanning from 1966 to 2024, it fosters a comprehensive discourse on lipid-related research and innovation. As a renowned publication in the Q2 and Q3 quartiles across several categories, it supports the dissemination of high-quality research aimed at elucidating lipid functions and their implications in health and disease. Researchers and students alike will find this journal invaluable for staying updated with the latest developments and trends in lipid research.
AMERICAN JOURNAL OF CLINICAL NUTRITION
Empowering professionals with vital nutritional knowledge.The American Journal of Clinical Nutrition, published by Elsevier Science Inc, stands as a premier academic platform dedicated to advancing knowledge in the fields of clinical nutrition and dietary science. With its roots tracing back to 1952, this prestigious journal boasts rigorous peer-reviewed research, providing vital insights and evidence-based findings that cater to the ever-evolving landscape of nutrition and health care. Affiliated with a strong reputation, the journal holds an impressive impact factor and is ranked in the top quartile (Q1) in both Nutrition and Dietetics and Medicine (miscellaneous), underscoring its significance in the academic community. With current Scopus rankings placing it #7 in Nursing and Nutrition and Dietetics and #20 in Medicine, it serves as an essential resource for researchers and practitioners seeking to stay at the forefront of clinical nutritional science. This journal not only disseminates groundbreaking research but also fosters collaborations among scholars, enhancing the clinical implications of nutrition practices globally. Access to the journal may vary, given its non-open access format; however, its contributions remain indispensable to professionals and students alike striving to deepen their understanding of clinical nutrition.
Journal of the ASEAN Federation of Endocrine Societies
Connecting Minds: Fostering Endocrine Research Across BordersWelcome to the Journal of the ASEAN Federation of Endocrine Societies, a pioneering publication dedicated to advancing knowledge and research in the fields of Endocrinology, Diabetes, and Metabolism. Established by the ASEAN Federation Endocrine Society and open access since 2011, this journal enhances the dissemination of critical findings and encourages collaboration among professionals and researchers across Southeast Asia and beyond. With an ISSN of 0857-1074 and E-ISSN of 2308-118X, the journal is indexed within Quartile 4 in the 2023 rankings of its categories, reflecting its commitment to providing a platform for scholarly work despite its emerging status. Situated in the Philippines, the journal focuses on the latest trends, treatments, and innovative research approaches in endocrinology, making it an essential resource for academics, clinicians, and students alike. We invite you to explore our content and contribute to advancing the endocrine sciences.
Lipids in Health and Disease
Bridging the gap between lipid metabolism and clinical practice.Lipids in Health and Disease, published by BMC, stands as a leading open-access journal dedicated to advancing the understanding of lipid metabolism and its implications for health and disease. Since its inception in 2002, this journal has fostered accessibility to cutting-edge research, ensuring that knowledge in this vital field is disseminated widely to researchers, clinicians, and students worldwide. With a commendable Q1 ranking in multiple categories including Clinical Biochemistry and Endocrinology, Diabetes and Metabolism, it appeals to a diverse readership, positioning itself at the forefront of research in biochemistry and medicine. It boasts an impressive Scopus rank, where it excels in areas such as Endocrinology, Diabetes and Metabolism and Clinical Biochemistry, making it an essential resource for those looking to deepen their understanding of lipid biology and its clinical applications. Researchers can share and access findings that have significant implications for public health and disease prevention, emphasizing the journal's commitment to fostering innovation and collaboration in the scientific community.